Department of Respiration, The People's Hospital of Zhangqiu Area, Jinan 250200, China.
Occupational Disease Department, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250001, China.
J Healthc Eng. 2022 Apr 11;2022:2223149. doi: 10.1155/2022/2223149. eCollection 2022.
Long noncoding RNA (lncRNA) SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1), which acts as an oncogene in various cancers, can promote tumors progression. The study aimed to explore the role and molecular mechanism of SBF2-AS1 in nonsmall cell lung cancer (NSCLC).
qRT-PCR was introduced to detect SBF2-AS1 and miR-520a-3p expression in NSCLC. The effects of SBF2-AS1 and miR-520a-3p on the proliferation, migration, and invasion of NSCLC cells were assessed through cell counting kit-8 (CCK-8) and transwell assay. Furthermore, the relationship of SBF2-AS1 and miR-520a-3p was verified by the RNA immunoprecipitation (RIP) assay, dual-luciferase assay, and Spearman correlation analysis.
In NSCLC tissues, SBF2-AS1 was highly expressed, while miR-520a-3p expression has decreased. The overall survival of NSCLC patients with high SBF2-AS1 expression was lower. SBF2-AS1 silencing repressed the proliferation, migration, and invasion of NSCLC cells. SBF2-AS1 directly interacted with miR-520a-3p, and a negative relationship was observed between their expression levels in NSCLC tissues. More importantly, the suppression of SBF2-AS1 silencing on the proliferation, migration, and invasion in NSCLC cells was counteracted by miR-520a-3p inhibition.
SBF2-AS1 accelerated the proliferation, migration, and invasion of NSCLC cells via mediating miR-520a-3p, thus promoting NSCLC progression.
长链非编码 RNA(lncRNA)SET 结合因子 2(SBF2)反义 RNA1(SBF2-AS1)作为多种癌症中的致癌基因,能够促进肿瘤进展。本研究旨在探讨 SBF2-AS1 在非小细胞肺癌(NSCLC)中的作用及分子机制。
采用 qRT-PCR 检测 NSCLC 中 SBF2-AS1 和 miR-520a-3p 的表达。通过细胞计数试剂盒-8(CCK-8)和 Transwell 实验评估 SBF2-AS1 和 miR-520a-3p 对 NSCLC 细胞增殖、迁移和侵袭的影响。进一步通过 RNA 免疫沉淀(RIP)实验、双荧光素酶报告基因实验和 Spearman 相关性分析验证 SBF2-AS1 和 miR-520a-3p 之间的关系。
在 NSCLC 组织中,SBF2-AS1 高表达,而 miR-520a-3p 表达降低。SBF2-AS1 高表达的 NSCLC 患者总生存率较低。沉默 SBF2-AS1 抑制 NSCLC 细胞的增殖、迁移和侵袭。SBF2-AS1 可与 miR-520a-3p 直接结合,且二者在 NSCLC 组织中的表达呈负相关。更为重要的是,miR-520a-3p 抑制剂可拮抗 SBF2-AS1 沉默对 NSCLC 细胞增殖、迁移和侵袭的抑制作用。
SBF2-AS1 通过介导 miR-520a-3p 加速 NSCLC 细胞的增殖、迁移和侵袭,从而促进 NSCLC 进展。